BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32967053)

  • 1. SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw.
    Yang G; Collins JM; Rafiee R; Singh S; Langaee T; McDonough CW; Holliday LS; Wang D; Lamba JK; Kim YS; Pelliccioni GA; Vaszilko M; Kosa JP; Balla B; Lakatos PA; Katz J; Moreb J; Gong Y
    J Bone Miner Res; 2021 Feb; 36(2):347-356. PubMed ID: 32967053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT1/HERC4 Locus Associated With Bisphosphonate-Induced Osteonecrosis of the Jaw: An Exome-Wide Association Analysis.
    Yang G; Hamadeh IS; Katz J; Riva A; Lakatos P; Balla B; Kosa J; Vaszilko M; Pelliccioni GA; Davis N; Langaee TY; Moreb JS; Gong Y
    J Bone Miner Res; 2018 Jan; 33(1):91-98. PubMed ID: 28856724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of SIRT1 Gene SNPs and Clinical Characteristics in Medication-Related Osteonecrosis of the Jaw.
    Bojtor B; Vaszilko M; Armos R; Tobias B; Podani J; Szentpeteri S; Balla B; Lengyel B; Piko H; Illes A; Kiss A; Putz Z; Takacs I; Kosa JP; Lakatos P
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication-Related Osteonecrosis of the Jaw in Cancer Patients: Result from the OneFlorida Clinical Research Consortium.
    Yang G; Williams R; Wang L; Farhadfar N; Chen Y; Loiacono AT; Bian J; Holliday LS; Katz J; Gong Y
    J Bone Miner Res; 2022 Dec; 37(12):2466-2471. PubMed ID: 36151778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Association Study Identified Chromosome 8 Locus Associated with Medication-Related Osteonecrosis of the Jaw.
    Yang G; Singh S; McDonough CW; Lamba JK; Hamadeh I; Holliday LS; Wang D; Katz J; Lakatos PA; Balla B; Kosa JP; Pelliccioni GA; Price DK; Van Driest SL; Figg WD; Langaee T; Moreb JS; Gong Y
    Clin Pharmacol Ther; 2021 Dec; 110(6):1558-1569. PubMed ID: 34390503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.
    Gkouveris I; Hadaya D; Elzakra N; Soundia A; Bezouglaia O; Dry SM; Pirih F; Aghaloo T; Tetradis S
    J Bone Miner Res; 2022 Sep; 37(9):1775-1786. PubMed ID: 35711109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
    Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
    BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of osteonecrosis of the jaw.
    Yang G; Singh S; Chen Y; Hamadeh IS; Langaee T; McDonough CW; Holliday LS; Lamba JK; Moreb JS; Katz J; Gong Y
    Bone; 2019 Jul; 124():75-82. PubMed ID: 31022475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis.
    Cui Y; Zhang W; Yang P; Zhu S; Luo S; Li M
    Free Radic Biol Med; 2023 Sep; 206():33-49. PubMed ID: 37364692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between single nucleotide polymorphism in promoter region of SIRT1 gene and senile degenerative heart valvular disease].
    Song ZP; Li JR; Gao R; Cui YH; Pang SC; Yan B
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):991-996. PubMed ID: 32294855
    [No Abstract]   [Full Text] [Related]  

  • 11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
    Guo Z; Cui W; Que L; Li C; Tang X; Liu J
    Int J Oral Maxillofac Surg; 2020 Mar; 49(3):298-309. PubMed ID: 31445964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
    Yuan A; Munz A; Reinert S; Hoefert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress in the treatment and prevention of medication-related osteonecrosis of the jaw].
    Xu LC; Li YF
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Jul; 55(7):509-514. PubMed ID: 32634892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical values of serum Semaphorin 4D (Sema4D) in medication‑related osteonecrosis of the jaw.
    Mu H; Pang Y; Liu L; Liu J; Liu C
    Eur J Med Res; 2023 Mar; 28(1):140. PubMed ID: 36998031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ).
    Aguirre JI; Castillo EJ; Kimmel DB
    Bone; 2021 Dec; 153():116168. PubMed ID: 34487892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Segmentation Analysis of the Radiological Changes by Using ITK-SNAP: Risk Assessment of the Severity and Recurrence of Medication-related Osteonecrosis of the Jaw.
    Zhou YQ; Son GH; Shi YQ; Yu YJ; Li MY; Zhang Q; Zou DH; Zhang ZY; Yang C; Wang SY
    Int J Med Sci; 2021; 18(10):2209-2216. PubMed ID: 33859529
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic predisposition for medication-related osteonecrosis of the jaws: a systematic review.
    Sandro Pereira da Silva J; Pullano E; Raje NS; Troulis MJ; August M
    Int J Oral Maxillofac Surg; 2019 Oct; 48(10):1289-1299. PubMed ID: 31097230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
    Ngoc Thuy Tran V; Chaisuparat R
    J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.